Atlas Trials

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Clinical trial NCT01626456 · COMPLETED

Trial details

NCT number
NCT01626456
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-06-01
Primary completion
2015-04-01
Enrollment
478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.